Finding the "Sweet Spot": Sharing the decision-making in ADHD treatment selection

Area of Science:

• Neurodevelopmental disorders
• Pharmacological treatments
• Pediatric medicine

Background:

• Stimulants are a primary treatment for attention-deficit/hyperactivity disorder (ADHD).
• Personalized medication selection involves optimizing duration and dosage.
• Liquid stimulants allow for titration and caregiver involvement in medication management.

Purpose of the Study:

• To present a communication strategy for shared decision-making in ADHD medication selection.
• To enhance parental comfort and informed consent regarding stimulant therapy.

Main Methods:

• A case series approach was used to illustrate the communication method.
• Focus on shared decision-making principles between clinicians and caregivers.
• Utilizing liquid stimulants for flexible dosage adjustments.

Main Results:

• The described method facilitates informed decisions for parents of newly diagnosed ADHD patients.
• Caregivers reported increased comfort with the medication regimen.
• Shared decision-making promotes a sense of control in managing ADHD treatment.

Conclusions:

• Effective communication and information sharing are crucial in ADHD pharmacotherapy.
• This case series demonstrates the utility of a collaborative approach.
• Healthcare providers should maintain open communication and encourage parental concerns regarding ADHD medication.